A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan

Summary

Dengue fever is caused by an infection with the dengue virus. Vaccination with TDV can help prevent dengue fever. The main purpose of this study is to learn about TDV's ability to create an immune response in adults, adolescents, and children administered. In this study, participants will receive 2 vaccinations with TDV (the second 3 months after the first). During the study, participants will visit their study clinic 5 times. Participants will be in this study for approximately 270 days (9 months).

Timeline

Start

2025-01-31

Primary completion

2025-07-09

Completion

2025-12-17

Drugs

Indications